Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Integrilin 20mg/10ml solution for injection vials
0209000X0BBAAAA
|
Integrilin | Eptifibatide | Cardiovascular System | No data available |
|
Integrilin 75mg/100ml solution for infusion vials
0209000X0BBABAB
|
Integrilin | Eptifibatide | Cardiovascular System | No data available |
|
Irbesartan 100mg/5ml oral suspension
0205052I0AAAMAM
|
Irbesartan | Irbesartan | Cardiovascular System | No data available |
|
Irbesartan 20mg oral powder sachets
0205052I0AAAJAJ
|
Irbesartan | Irbesartan | Cardiovascular System | No data available |
|
Irbesartan 300mg oral powder sachets
0205052I0AAAIAI
|
Irbesartan | Irbesartan | Cardiovascular System | No data available |
|
Irbesartan 30mg oral powder sachets
0205052I0AAAKAK
|
Irbesartan | Irbesartan | Cardiovascular System | No data available |
|
Irbesartan 37.5mg oral powder sachets
0205052I0AAALAL
|
Irbesartan | Irbesartan | Cardiovascular System | No data available |
|
Ismelin 10mg/1ml solution for injection ampoules
0205030N0BBACAA
|
Ismelin (Systemic) | Guanethidine monosulfate | Cardiovascular System | No data available |
|
Ismo 40 tablets
0206010K0BDADAD
|
Ismo | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Isocard 30mg/dose transdermal spray
0206010I0BVAAAU
|
Isocard | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Isoket 0.05% solution for infusion 50ml bottles
0206010I0BGAHAY
|
Isoket | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Isoket 0.1% solution for infusion 50ml bottles
0206010I0BGAFA0
|
Isoket | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Isoket 0.1% solution for injection 10ml ampoules
0206010I0BGAEAC
|
Isoket | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Isoket 5 tablets
0206010I0BGAAAK
|
Isoket | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Isomide CR 250mg capsules
0203020G0BBAAAB
|
Isomide CR | Disopyramide phosphate | Cardiovascular System | No data available |
|
Isoprenaline hydrochloride 1mg/5ml inf vials
0207020AAAAAAAA
|
Isoprenaline hydrochloride | Isoprenaline hydrochloride | Cardiovascular System | No data available |
|
Isoprenaline hydrochloride 200micrograms/1ml inf ampoules
0207020AAAAABAB
|
Isoprenaline hydrochloride | Isoprenaline hydrochloride | Cardiovascular System | No data available |
|
Isordil 10mg tablets
0206010I0BLABAD
|
Isordil | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Isordil 30mg tablets
0206010I0BLACAF
|
Isordil | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Isordil 5mg tablets
0206010I0BLAAAK
|
Isordil | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Isordil Tembids 40mg modified-release capsules
0206010I0BLADAB
|
Isordil | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Isosorbide dinitrate 1.25mg/dose sublingual spray sugar free
0206010I0AAAMAM
|
Isosorbide dinitrate (Angina) | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Isosorbide dinitrate 10mg/10ml inj ampoules
0206010I0AAACAC
|
Isosorbide dinitrate (Angina) | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Isosorbide dinitrate 10mg/5ml oral liquid
0206010I0AAARAR
|
Isosorbide dinitrate (Angina) | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Isosorbide dinitrate 20mg modified-release capsules
0206010I0AAAAAA
|
Isosorbide dinitrate (Angina) | Isosorbide dinitrate | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.